TrialAmerican journal of hematology2020

Phase I/II study of dasatinib in combination with decitabine in patients with accelerated or blast phase chronic myeloid leukemia.

Yasmin Abaza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.